跳至主要内容
临床试验/NCT00934011
NCT00934011已完成不适用

Comparative Study of C-reactive Protein vs. Procalcitonin to Guide Antibiotic Therapy in Patients With Severe Sepsis and Septic Shock Admitted to the Intensive Care Unit.

Federal University of Minas Gerais1 个研究点 分布在 1 个国家目标入组 94 人开始时间: 2009年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
94
试验地点
1
主要终点
Days alive without antibiotics

研究概览

简要总结

In this study the investigators aim to test if C-reactive protein (CRP)or procalcitonin(PCT) - guided strategy allows to reduce the antibiotic use in patients wiht severe sepsis and septic shock. Therefore, the safety of this intervention will be carefully measured.

详细描述

Methods

  • Patients and settings: Prospective controlled randomized open interventional study of antibiotic therapy in adult with severe sepsis or septic shock, admitted to the intensive care unit.

The study will be conducted in the intensive care unit (ICU) of the University Hospital Risoleta Tolentino Neves of the Federal University of Minas Gerais, Brazil. This is a 30-bed ICU with medical and surgical patients. All patients with suspected severe sepsis or septic shock admitted to the ICU will be assessed for eligibility. Patients developing severe sepsis or septic shock during their ICU stay will be also considered for enrollment.

Cultures of urine, blood, bronchoalveolar lavage fluid, and tracheal aspirates will be performed on admission and during ICU stay as clinically indicated. Blood gases and imaging exams will also be performed as clinically indicated, similarly in both groups.

  • Interventions:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age > 17 years
  • patients in intensive care unit
  • signed informed consent
  • suspected or confirmed severe sepsis or septic shock

排除标准

  • Infections caused by Listeria spp, Legionella pneumophilia, Mycobacterium tuberculosis
  • Bacteremia due S. aureus
  • Infections requiring prolonged therapies, such as endocarditis, cerebral abscess, chronic osteomyelitis
  • Suspected or confirmed infection caused by virus, parasites
  • Infections caused by P. aeruginosa ou A. baumannii
  • Severe immunosuppression (ex: AIDS, post bone-marrow transplant,cystic fibrosis)
  • Traumatism latest five days
  • Surgery latest 5 days
  • Carcinoid tumor, lung cancer, medullary thyroid cancer

结局指标

主要结局

Days alive without antibiotics

时间窗: 28 days

Total antibiotic exposure days per 1,000 days

时间窗: 28 days

Duration of antibiotic therapy for the first episode of infection

时间窗: 28 days

次要结局

  • All cause 28-day mortality(28 days)
  • In-hospital mortality(28 days)
  • sepsis-associated death(28 days)
  • clinical cure rate(28 days)
  • Nosocomial infection rate(28 days)
  • Nosocomial superinfection (diagnosed more than 48hous after discontinuation of the antibiotic therapy given to the first episode of infection)(28 days)
  • Length of hospital stay(The whole hospitalization)
  • Isolation of resistant bacteria(28 days)
  • Infection relapse (diagnosed less than 48h after antibiotic discontinuation)(48 hours)
  • Length of ICU stay(Whole hospitalization)

研究者

发起方
Federal University of Minas Gerais
申办方类型
Other
责任方
Principal Investigator
主要研究者

Vandack Alencar Nobre

Associate Professor, PhD

Federal University of Minas Gerais

研究点 (1)

Loading locations...

相似试验